Virtus ETF Advisers LLC Alaunos Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$196 Million
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.41 - $1.24 $53,879 - $162,952	-131,413 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $4,828 - $9,111	-7,788 Reduced 5.59%	131,413 $86,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $73,183 - $126,896	67,141 Added 93.17%	139,201 $152,000
Q3 2021 Nov 15, 2021	SELL	$1.44 - $2.73 $5,423 - $10,281	-3,766 Reduced 4.97%	72,060 $131,000
Q2 2021 Aug 10, 2021	SELL	$2.63 - $3.67 $56,158 - $78,365	-21,353 Reduced 21.97%	75,826 $200,000
Q1 2021 May 17, 2021	BUY	$2.82 - $5.6 $4,810 - $9,553	1,706 Added 1.79%	97,179 $350,000
Q4 2020 Feb 12, 2021	SELL	$2.09 - $3.09 $7,597 - $11,232	-3,635 Reduced 3.67%	95,473 $241,000
Q3 2020 Nov 13, 2020	SELL	$2.39 - $3.43 $32,291 - $46,342	-13,511 Reduced 12.0%	99,108 $250,000
Q2 2020 Aug 05, 2020	BUY	$2.2 - $3.71 $87,315 - $147,246	39,689 Added 54.42%	112,619 $369,000
Q1 2020 May 14, 2020	SELL	$1.9 - $4.98 $20,212 - $52,977	-10,638 Reduced 12.73%	72,930 $179,000
Q4 2019 Feb 13, 2020	BUY	$3.95 - $5.35 $138,897 - $188,127	35,164 Added 72.65%	83,568 $394,000
Q3 2019 Nov 12, 2019	SELL	$4.13 - $6.94 $11,134 - $18,710	-2,696 Reduced 5.28%	48,404 $207,000
Q2 2019 Aug 13, 2019	SELL	$3.98 - $6.2 $163,371 - $254,497	-41,048 Reduced 44.55%	51,100 $298,000
Q1 2019 May 14, 2019	SELL	$2.0 - $4.4 $21,480 - $47,256	-10,740 Reduced 10.44%	92,148 $355,000
Q4 2018 Feb 05, 2019	SELL	$1.61 - $3.62 $12,797 - $28,775	-7,949 Reduced 7.17%	102,888 $192,000
Q3 2018 Nov 14, 2018	SELL	$2.26 - $3.27 $179,048 - $259,065	-79,225 Reduced 41.68%	110,837 $355,000
Q2 2018 Aug 10, 2018	BUY	$3.02 - $4.94 $38,242 - $62,555	12,663 Added 7.14%	190,062 $574,000
Q1 2018 May 14, 2018	BUY	$3.46 - $5.14 $331,035 - $491,769	95,675 Added 117.07%	177,399 $695,000
Q4 2017 Feb 14, 2018	BUY	$4.0 - $6.54 $90,860 - $148,556	22,715 Added 38.49%	81,724 $338,000
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $26,931 - $35,458	5,397 Added 10.07%	59,009 $362,000
Q2 2017 Aug 14, 2017	BUY	N/A	53,612	53,612 $333,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account